Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.000001 par value
-
Shares outstanding
-
15,729,081
-
Total 13F shares
-
13,847,659
-
Share change
-
+427,618
-
Total reported value
-
$581,113,931
-
Price per share
-
$41.96
-
Number of holders
-
85
-
Value change
-
+$18,023,436
-
Number of buys
-
40
-
Number of sells
-
24
Institutional Holders of Neurogene Inc. - Common Stock, $0.000001 par value (NGNE) as of Q3 2024
As of 30 Sep 2024,
Neurogene Inc. - Common Stock, $0.000001 par value (NGNE) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,847,659 shares.
The largest 10 holders included
BlackRock, Inc., EcoR1 Capital, LLC, Samsara BioCapital, LLC, RTW INVESTMENTS, LP, GREAT POINT PARTNERS LLC, Redmile Group, LLC, FMR LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, and Casdin Capital, LLC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.